HEALWELL AI and WELL Health Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research
- HEALWELL and WELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
- WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
- The first commercial application combines WELL's expansive clinical footprint with HEALWELL's DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.
Toronto, Ontario and Vancouver, British Columbia--(Newsfile Corp. - February 19, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL"), a healthcare artificial intelligence company focused on preventative care, and WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a technology-enabled healthcare company operating outpatient clinics that leverage scalable digital health solutions, are jointly pleased to announce the launch of the first phase of WELLTRUST™, a platform enabling secure, consent-driven patient identification for clinical research within WELL-operated clinics in Canada.
WELLTRUST accelerates clinical research recruitment by enabling patients interested in clinical trials and research to consent to future outreach. By combining WELL's extensive clinical footprint with HEALWELL's advanced AI capabilities, WELLTRUST provides a scalable, privacy-preserving infrastructure that accelerates research by developing a database of individuals who are interested in participating in such research. Patients who are not interested in participating in WELLTRUST can safely and securely decline participation and continue receiving care at WELL clinics as they had before.
Dr. Alexander Dobranowski, President of HEALWELL AI, commented, "WELLTRUST embodies our commitment to responsible and impactful AI in healthcare. By integrating HEALWELL's data and AI capabilities directly into WELL's clinical environment, we are creating an advanced AI powered ethical patient identification and research acceleration platform. This will accelerate research and patient access to potentially life-saving innovations while respecting high standards of privacy and patient autonomy."

